557 results
Page 3 of 28
8-K
EX-10.1
tsenn9
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
dabjkrvem5sjhy7vs5l
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.4
z7prpirg l6
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
ky4z e0k6
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.3
tbnrteaxj0c8fv8rxt
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.2
luk8puxkqus
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.1
7s0cm m72
23 Mar 22
Business combination disclosure
5:29pm
8-K
2l5cqemi
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.3
vpe2umb7s 4ahs8hp9
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
aze35392iy
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.2
w5xs 457cvvha58
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
b79ux1e75
17 Feb 22
Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
4:03pm
8-K
ypfhkxsd2fxy aiprv7
14 Jul 21
Ligand Pharmaceuticals Appoints Dr. Jennifer Cochran to its Board of Directors
4:08pm
8-K
m5tgcj ban89
7 Jun 21
Submission of Matters to a Vote of Security Holders
12:00am
DEFA14A
58x gpo4uqj94jvysxm
18 May 21
Additional proxy soliciting materials
5:00pm